Related references
Note: Only part of the references are listed.Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial
Lieselotte Lemoine et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
Jason M. Foster et al.
JAMA NETWORK OPEN (2019)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Can Yurttas et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis
V. Leung et al.
EJSO (2017)
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
Jan Franko et al.
LANCET ONCOLOGY (2016)
The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study
D. Hompes et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
The American Society of Peritoneal Surface Malignancies Evaluation of HIPEC with Mitomycin C Versus Oxaliplatin in 539 Patients with Colon Cancer Undergoing a Complete Cytoreductive Surgery
Arancha Prada-Villaverde et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients
Edward A. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?
Diane Goere et al.
ANNALS OF SURGERY (2013)
Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
Andreas Andreou et al.
ANNALS OF SURGERY (2012)
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
J. Segelman et al.
BRITISH JOURNAL OF SURGERY (2012)
Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis
Francois Quenet et al.
ANNALS OF SURGERY (2011)
Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.
F. Cavaliere et al.
EJSO (2011)
Toward Curative Treatment of Peritoneal Carcinomatosis From Nonovarian Origin by Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy A Multi-Institutional Study of 1290 Patients
Olivier Glehen et al.
CANCER (2010)
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
Terence C. Chua et al.
ANNALS OF SURGERY (2009)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Exposure-response relationships for oxaliplatin-treated colon cancer cells
Mark N. Kirstein et al.
ANTI-CANCER DRUGS (2008)
Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusion
Olivier Glehen et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis
Philippe Esquis et al.
ANNALS OF SURGERY (2006)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study
O Glehen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias et al.
ANNALS OF ONCOLOGY (2002)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
